These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 458153)

  • 1. Effects of C-1 on the size of soluble immune aggregates and on their processing by macrophages.
    Kijlstra A; van Es LA; Daha MR
    J Immunol; 1979 Aug; 123(2):640-5. PubMed ID: 458153
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of complement in the binding and degradation of immunoglobulin aggregates by macrophages.
    Kijlstra A; van Es LA; Daha MR
    J Immunol; 1979 Dec; 123(6):2488-93. PubMed ID: 501082
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhanced alternative complement pathway-dependent degradation of soluble immunoglobulin aggregates by macrophages.
    Daha MR; Van Es LA
    Immunology; 1981 Jul; 43(3):513-8. PubMed ID: 7251062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C1- inactivator: its efficiency as a regulator of classical complement pathway activation by soluble IgG aggregates.
    Doekes G; van Es LA; Daha MR
    Immunology; 1983 Jun; 49(2):215-22. PubMed ID: 6852866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of lidocaine on the processing of soluble immune aggregates and immune complexes by peritoneal macrophages.
    Hijlstra A; Van Dorp W; Daha MR; Leslie GQ
    Immunology; 1980 Sep; 41(1):237-44. PubMed ID: 7429552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the interaction of rabbit C1q with sheep and rabbit immune complexes.
    Liberti PA; Baillie RD; Milligan KF; Bausch DM
    J Immunol; 1979 Nov; 123(5):2212-9. PubMed ID: 114586
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhanced degradation of soluble immunoglobulin aggregates by macrophages in the presence of complement.
    Kijlstra A; Van Es LA; Daha MR
    Immunology; 1979 Jul; 37(3):673-80. PubMed ID: 500123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced degradation of soluble immune complexes by guinea-pig peritoneal macrophages in the presence of complement.
    Kijlstra A; van Es LA; Daha MR
    Immunology; 1981 Jun; 43(2):345-52. PubMed ID: 7251057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of activation of the first component of complement by a univalent hapten-IgG antibody complex.
    Goers JW; Ziccardi RJ; Schumaker VN; Glovsky MM
    J Immunol; 1977 Jun; 118(6):2182-91. PubMed ID: 559020
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of cellular Fc and C3 receptors on the complement-dependent degradation of stable soluble immunoglobulin aggregates by normal and trypsin-treated peritoneal macrophages.
    Daha MR; van Es LA
    Immunology; 1982 Sep; 47(1):203-9. PubMed ID: 7118161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of the complement activation capacity of soluble IgG aggregates and immune complexes by IgM-rheumatoid factor.
    Doekes G; Schouten J; Cats A; Daha MR
    Immunology; 1985 Jul; 55(3):555-64. PubMed ID: 4018839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemiluminescence of guinea pig peritoneal macrophages stimulated by immune precipitates and soluble immune complexes.
    Connell PA; Seehra MS; Leslie RG; Reeves WG
    Eur J Immunol; 1980 Dec; 10(12):966-8. PubMed ID: 7202479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Composition and biologic properties of soluble IgG-anti-IgG immune complexes: effects of variations in the specificity of rabbit antibodies to different structural components of human IgG.
    Arend WP; Sturge JC
    J Immunol; 1979 Jul; 123(1):447-54. PubMed ID: 448156
    [No Abstract]   [Full Text] [Related]  

  • 14. Structural studies of Fc receptors. I. Binding properties, solubilization, and partial characterization of fc receptors of macrophages.
    Yagawa K; Onoue K; Aida Y
    J Immunol; 1979 Jan; 122(1):366-73. PubMed ID: 33218
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of aggregate size on the binding and activation of the first component of human complement by soluble IgG aggregates.
    Doekes G; Vanes LA; Daha MR
    Immunology; 1982 Apr; 45(4):705-13. PubMed ID: 7068172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble immune complex triggering of a respiratory burst in macrophages: the role of complex aggregation at the phagocyte surface.
    Vieweg R; Leslie RG
    Eur J Immunol; 1987 Jan; 17(1):149-51. PubMed ID: 3028821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
    Heinz HP; Burger R; Golan MD; Loos M
    J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between the binding ability and the rate of activation of the complement component C1.
    Folkerd EJ; Gardner B; Hughes-Jones NC
    Immunology; 1980 Sep; 41(1):179-85. PubMed ID: 7429549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement-dependent inhibition of degradation of soluble immune complexes and immunoglobulin aggregates by thioglycollate-stimulated peritoneal macrophages.
    Daha MR; Van Es LA
    Immunology; 1983 Sep; 50(1):107-11. PubMed ID: 6224740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune complexes and triggering of cellular mechanisms.
    Stanworth DR
    Haematologia (Budap); 1978-1979; 12(1-4):47-54. PubMed ID: 395042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.